フェロプトーシスに関連した遺伝子と潰瘍性大腸炎の有意な相関:診断と治療への影響
Kai Zhang1, Kailing Wang2, Chengzhao Weng3
1Department of Gastroenterology and Hepatology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China. zhang.kai@zsxmhospital.com.
European journal of medical research
|August 29, 2025
まとめ
この研究は,炎症性腸疾患 (IBD) の1種である潰瘍性大腸炎 (UC) に関する重要な遺伝子を特定した. これらの遺伝子は診断の可能性を示し 免疫細胞の浸透と相関し 生物学的治療の洞察を提供します
科学分野:
- 分子生物学
- 免疫学
- 胃腸内科
背景:
- 潰瘍性大腸炎 (UC) は,炎症性腸疾患 (IBD) の主要な形態である.
- フェロプトーシスという 制御された細胞死経路は 様々な病気に関与しています
- UCにおけるフェロプトーシスの役割を理解することは,標的治療の開発に不可欠です.
研究 の 目的:
- 潰瘍性大腸炎 (UC) の主要なフェロプトーシス関連遺伝子を特定する.
- UCにおけるこれらの遺伝子の診断および治療の可能性を評価する.
- 免疫細胞の浸透とUCの関係を探るため
主な方法:
- 遺伝子発現オムニバスデータベースからの遺伝子発現データのバイオインフォマティック分析を用いた.
- デクストラン硫酸ナトリウム塩 (DSS) で誘発されたマウス大腸炎のモデルで有効なキー遺伝子発現.
- 免疫細胞の浸透とUC患者の特定されたフェロプトーシス関連遺伝子との相関を分析した.
主要な成果:
- UCで91のフェロプトーシス関連遺伝子を特定した.
- 4つの遺伝子 (TIMP1,LPIN1,SOCS1,CD44) は診断上の価値を示し,マウス大腸炎モデルで上位調節された.
- これらの遺伝子は,治療に反応する患者と活性UC患者とを区別し,免疫細胞タイプ (中性細胞,マクロファージ,B細胞,NK細胞) と相関していた.
結論:
- UCにおける免疫細胞の浸透はフェロプトーシスと有意に関連している.
- 主要なフェロプトーシス関連遺伝子はUCの診断と治療反応の予測の可能性を持っています.
- これらの発見は,UCの基礎にある分子メカニズムを理解し,新しい生物学的治療法を開発するのに寄与しています.
関連する概念動画
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
316
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
316
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
200
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
200
01:29Drugs for Treatment of Ulcerative Colitis in IBD
236
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
236
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
413
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
413
01:28Peptic Ulcer Disease II: Pathophysiology
827
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
827
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
238
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
238